SARA WALKER: Open Payments
NPI 1740959550 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 7 payments from 6 companies in 2025. Trend: 2023 $55 · 2024 $407 · 2025 $330
Food & beverage: $240Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $114 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| GENZYME CORPORATION | 1 | $36 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: SARCLISA, RYBREVANT, OJJAARA, PLUVICTO, LYNPARZA, LEQVIO.
Industry payments across CA — which companies pay providers there.
